Background {#Sec1}
==========

Policy has a tremendous potential to improve population health \[[@CR1], [@CR2]\]. The extent to which policy produces such outcomes, however, often depends upon the degree to which it is informed by scientific knowledge and aligned with evidence-based interventions \[[@CR3]--[@CR5]\]. Unfortunately, research typically plays a minor role in policymaking processes \[[@CR6], [@CR7]\]. For decades, scholars have documented myriad barriers to translating research into policy---including political influences, economic constraints, scientific uncertainty, and institutional culture \[[@CR8]--[@CR20]\].

The field of health policy dissemination and implementation research (policy D&I) exists to address these challenges. Policy D&I is focused on generating knowledge to effectively spread research evidence among policymakers and integrate evidence-based interventions into policy designs \[[@CR5]\]. Policy D&I, known as policy "knowledge translation and exchange" outside of the USA, has evolved over the past 40 years. The 1970s and 1980s were marked by interest in how social science research was used in public policymaking and saw the development of key contributions to the field---such as Weiss' typology of research evidence \[[@CR7]\] and Caplan's two communities theory of knowledge utilization \[[@CR17]\]. In the 1990s and 2000s, frameworks and instruments for policy D&I emerged \[[@CR21]--[@CR25]\] and the field was embraced within the discipline of public health \[[@CR9], [@CR26], [@CR27]\]. Today, policy D&I is a priority of the World Health Organization \[[@CR28], [@CR29]\] and a major focus of journals such as *Health Research Policy and Systems* and *Evidence & Policy.*

The history of policy D&I has demonstrated that government funding is essential for a county to develop and maintain a robust policy D&I research infrastructure \[[@CR22], [@CR30]\]. Outside of the USA, governments have made sustained investments in policy D&I research and initiatives to promote the use of research evidence in health policymaking. Examples include the Canadian Institutes of Health Research's integrated knowledge translation programs, the National Health and Medical Research Council of Australia's Partnership Projects and Centres, and the UK National Institute for Health Research's Collaboration for Leadership in Applied Health Research and Care. While national governments have invested in policy D&I abroad, policy D&I research has largely existed outside of the mainstream, government-funded health research enterprise in the USA \[[@CR6]\]. This is potentially changing, however, as the National Institutes of Health (NIH)---the largest government funder of health research in the USA---has recently invested in the broader field of D&I research and identified policy D&I as a priority \[[@CR31]\].

In 2002, the National Institute of Mental Health issued a Program Announcement (PAR) entitled "Dissemination and Implementation Research in Mental Health" that highlighted the importance of developing effective strategies to disseminate research findings to the policymakers \[[@CR32]\]. In 2005, the PAR was re-issued under the broader name "Dissemination and Implementation Research in Health" (D&IRH) with more participating Institutes (e.g., the National Cancer Institute, National Institute on Drug Abuse) \[[@CR33]\]. In 2007, the NIH Center for Scientific Review created a permanent D&IRH study section to evaluate D&I proposals, re-affirming NIH's investment in the field \[[@CR34]\]. In 2013, the "D&IRH" PAR was re-issued, this time with a greater emphasis on policy D&I research \[[@CR35]\]. For example, the PAR encouraged applications that "address\[ed\] the complexity of bridging research, policy and practice."

NIH has expressed interest in policy D&I research, but the extent to which it has funded research in this area is unclear. Two recent studies reviewed NIH D&I funding related to specific topics; one study focused on nursing \[[@CR36]\] and the other focused on cancer control \[[@CR37]\]. A similar review of policy D&I research is needed to assess growth of the field and identify funding gaps. Such a study would support growth in the field of policy D&I in the USA by providing investigators with a menu of approaches to policy D&I research that can be adopted and adapted when developing proposals. This article reports the results of a study that was conducted to address these knowledge gaps. The aims of the study were to: (1) determine the extent to which policy D&I research has been funded by NIH between 2007 and 2014, (2) identify trends in NIH-funded policy D&I research, and (3) describe the characteristics of NIH-funded policy D&I research projects.

Methods {#Sec2}
=======

We used the NIH Research Portfolio Online Reporting Tool \[[@CR38]\] to identify all projects that received funding during any US fiscal year between 2007 and 2014 through the D&I funding opportunity announcements (FOAs) Dissemination and Implementation Research in Health (PARs: 06-039, 06-071, 06-072, 06-520, 06-521, 07-086, 10-038, 10-039, 10-040, 13-054, 13-055, 13-056) or Dissemination and Implementation Research in Mental Health (PA 02-131). We selected 2007 as the starting point because it was the first year that projects supported by the Dissemination and Implementation Research in Health FOAs received funding. For each project, we extracted the title, abstract, project terms, award amount per fiscal year, funding mechanism, and Institute.

Our review was guided by Bogenschneider's definition of policy as: "the development, enactment, and implementation of a plan or course of action carried out through law, rule, code, or other mechanism in the public or private sector" \[[@CR5]\]. Accordingly, we identified potential policy D&I projects by searching the project title, abstract, and term fields for mentions of "policy," "policies," "law," "legal," "legislation," "ordinance," "statute," "regulation," "regulatory," "code," or "rule." Two coders then independently reviewed project abstracts and developed preliminary coding categories to capture project characteristics. These categories reflected themes in that data, categories used in previous NIH D&I funding reviews \[[@CR36], [@CR37]\], and policy D&I scholarship \[[@CR3]--[@CR6], [@CR8], [@CR9]\]. The coders then jointly developed a coding guide and independently re-reviewed and coded the projects. Because many projects were not exclusively focused on policy D&I, projects were coded according to their policy D&I features. Incongruent coding decisions were identified in \<10 % of projects and resolved through discussions.

We classified a project as policy D&I if it explicitly proposed to conduct empirical research about the "content" of a policy (e.g., analysis of the text of clean indoor air laws), the "process" through which it was developed (e.g., assessment of how state legislators use research evidence when developing clean indoor air laws), or the "outcomes" it produced (e.g., evaluation of the impacts of clean indoor air laws on cardiovascular health outcomes). These inclusion criteria were informed by Bogenschneider's definition of policy \[[@CR6]\] and domains of health policy research proposed by Brownson and colleagues \[[@CR3]--[@CR5]\]. For projects classified as policy D&I, we searched for its NIH project number in ClinicalTrials.gov \[[@CR39]\] and PubMed \[[@CR40]\] to obtain additional information and validate coding decisions.

We calculated the total dollar amount awarded through all NIH research grants and through the D&I FOAs, stratified by funding mechanism and Institute. We also calculated the amount awarded for policy D&I projects, and the percentage of total D&I FOA funding they comprised, within strata. Data were managed and analyzed in Microsoft Excel.

Results and discussion {#Sec3}
======================

Between 2007 and 2014, 146 projects were funded through the D&I FOAs, 12 (8.2 %) of which were classified as policy D&I research (Fig. [1](#Fig1){ref-type="fig"}). A total of \$16,177,250 was awarded for these projects, equivalent to 10.5 % of all funding through the D&I FOAs (Table [1](#Tab1){ref-type="table"}). The NIH Office of the Director allocated 69.7 % of its D&I FOA funding to a policy D&I project, indicating agency-level support for the field. The National Cancer Institute (NCI) was the primary funder of policy D&I research, supporting six projects which comprised 13.0 % of all NCI funding through the D&I FOAs. Some Institutes that were engaged in D&I funding---such as the National Institute of Nursing Research which funded seven D&I projects comprising over 1.0 % of the Institute's total research grant spending, a proportion larger than any other Institute---did not fund any policy D&I projects. Differences in policy D&I funding between Institutes could potentially be a reflection of varying levels of knowledge about policy D&I research among investigators within different health science disciplines or differences in the degree to which the disciplines are clinically, as opposed to policy, oriented.Fig. 1Flow diagram summarizing the process used to identify policy D&I research projects funded by NIH, federal fiscal years 2007--2014. *NIH* National Institutes of Health, *D&I* dissemination and implementation, *FOA*s funding opportunity announcements Table 1NIH-funded policy D&I research projects by funding mechanism, Institute, and percentage of all research funded through D&I FOAs, federal fiscal years 2007--2014Funding sourceNumber of projects funded through D&I FOAsAmount funded through D&I FOAs (%)^a^Number of policy D&I projects funded (%)^b^Amount funded for policy of D&I (%)^b^Total146\$154,339,271 (0.09)12 (8.2)\$16,177,250 (10.5)Funding mechanism R0182\$134,439,725 (0.19)7 (8.5)\$14,626,930 (10.9) R0312\$1,745,967 (0.25)1 (8.3)\$150,000 (8.6) R2151\$18,042,301 (0.36)4 (7.8)\$1,400,320 (7.8) R341\$111,278 (0.03)0 (0)\$0 (0)Institute NCI46\$47,631,105 (0.19)6 (13.0)\$5,993,592 (12.6) NIMH40\$51,237,349 (0.57)3 (7.5)\$4,328,310 (8.4) NIAID18\$13,093,827 (0.06)1 (5.6)\$320,720 (2.4) NIDA12\$11,691,400 (0.19)1 (8.3)\$1,872,963 (16.0) NHLBI8\$12,248,387 (0.07)1 (12.5)\$3,393,577 (27.7) NINR7\$8,983,908 (1.03)0 (0)\$0 (0) FIC4\$667,849 (0.29)0 (0)\$0 (0) OD3\$384,426 (0.02)1 (33.3)\$268,088 (69.7) NIDCR3\$2,538,584 (0.11)0 (0)\$0 (0) NCCAM2\$864,887 (0.17)0 (0)\$0 (0) NIDCD2\$352,052 (0.01)0 (0)\$0 (0) NINDS1\$2,601,603 (0.02)0 (0)\$0 (0) NIDDK1\$1,396,497 (0.01)0 (0)\$0 (0) NIAAA1\$408,039 (0.02)0 (0)\$0 (0) NIA1\$239,358 (0.00)0 (0)\$0 (0)*NIH* National Institutes of Health, *NCI* National Cancer Institute, *NIMH* National Institute of Mental Health, *NIDA* National Institute on Drug Abuse, *NHLBI* National Heart, Lung, and Blood Institute, *OD* NIH Office of the Director, *NIAID* National Institute of Allergy and Infectious Diseases, *NINR* National Institute of Nursing Research, *FIC* Fogarty International Center, *NIDCR* National Institute of Dental and Craniofacial Research, *NCCAM* National Center for Complementary and Alternative Medicine, *NIDCD* National Institute on Deafness and Other Communication Disorders, *NINDS* National Institute of Neurological Disorders and Stroke, *NIDDK* National Institute of Diabetes and Digestive and Kidney Diseases, *NIAAA* National Institute on Alcohol Abuse and Alcoholism, *NIA* National Institute on Aging, *D&I* dissemination and implementation, *FOA*s funding opportunity announcements^a^Percentages indicating the proportion of D&I funding within total NIH research grant spending category (e.g., proportion of research grant funding for R01 projects that were for D&I projects, \$134,439,725/\$71,808,892,375 = 0.19 %). Total research grant amounts for each NIH spending category are not shown. Source: <https://report.nih.gov/fundingfacts/fundingfacts.aspx>^b^Percentages indicating the proportion of policy D&I within total D&I category (e.g., proportion of R01 projects funded through D&I FOAs that were policy D&I projects, 7/82 = 8.5 %)

NIH funding for policy D&I increased between 2007 and 2014 (Fig. [2](#Fig2){ref-type="fig"}). Annual policy D&I funding increased by 98.9 % within this period, from \$1,584,327 in 2007 to \$3,151,286 in 2014. The proportion of funding awarded through the D&I FOAs that was for policy D&I projects ranged from 14.6 % in 2007 to 8.0 % in 2011. Between 2012 and 2013, funding decreased by 6.3 % for all NIH research grants and increased by 7.4 % for projects funded through the D&I FOAs and by 51.8 % for policy D&I projects.Fig. 2Annual trends in NIH funding for D&I research, federal fiscal years 2007--2014. "Policy D&I funding" and "all D&I FOA funding" in millions, "all NIH research grant funding" in billions, US dollars. *NIH* National Institutes of Health, *D&I* dissemination and implementation, *FOA*s funding opportunity announcements

NIH-funded policy D&I projects utilized a range of methodologies and data sources across different domains of policy research (Tables [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"}, Additional file [1](#MOESM1){ref-type="media"}). These projects were primarily focused on policy outcomes (66.7 %), implementation research (41.7 %), state-level policies (41.7 %), and the USA (83.3 %). Tobacco (33.3 %) and cancer control (25.0 %), for which evidence-based policy strategies exist \[[@CR41], [@CR42]\], were the most common topics of focus. Many projects combined survey (58.3 %) and interview (33.3 %) methods with analysis of archival data sources, such as medical records (25.0 %) and policy documents (25.0 %). It was unclear; however, the extent to which projects used true mixed-method designs (e.g., the results of one method informed data collection of the other, or the results of both methods were presented together).Table 2NIH-funded policy D&I research projects by study characteristics, federal fiscal years 2007--2014Study characteristicsNumber of policy D&I projects (%)^a^(*N* = 12)Domain of policy research Outcome8 (66.7 %) Process5 (41.7 %) Content1 (8.3 %)Type of policy Public (e.g., laws, regulations)6 (50.0 %) Heath care financing/reimbursement3 (25.0 %) Workplace2 (16.7 %) Clinical practice1 (8.3 %)Level of policy State5 (41.7 %) Local3 (25.0 %) Organization3 (25.0 %) National1 (8.3 %)Region of research focus USA10 (83.3 %) Outside of USA2 (16.7 %)Health issue Tobacco4 (33.3 %) Cancer3 (25.0 %) Drug abuse2 (16.7 %) Mental health2 (16.7 %) Child welfare2 (16.7 %)Implementation science objectives Implementation5 (41.7 %) Dissemination4 (33.3 %) Adoption2 (16.7 %) Sustainability1 (8.3 %)Study design Quasi-experimental5 (41.7 %) Non-experimental4 (33.3 %) Experimental3 (25.0 %)Methods used Quantitative, surveys7 (58.3 %) Qualitative, interviews4 (33.3 %) Quantitative, medical record review3 (25.0 %) Content analysis, document analysis3 (25.0 %) Qualitative, focus groups1 (8.3 %) Quantitative, agent-based modeling1 (8.3 %) Content analysis, media analysis1 (8.3 %)Data sourcePolicymakers3 (25.0 %)Policy documents3 (25.0 %)Healthcare providers3 (25.0 %)Administrative documents3 (25.0 %)Medical records3 (25.0 %)Community stakeholders2 (16.7 %)Media coverage1 (8.3 %)Unknown1 (8.3 %)*NIH* National Institutes of Health, *D&I* dissemination and implementation^a^Some percentages exceed 100 because categories were not mutually exclusive Table 3NIH-funded policy D&I research projects by individual project details, federal fiscal years 2007--2014 (*N* = 12)Project numberTitleObjectiveFunding sourceStart dateCountry of focusR01HL086450An intervention for promoting smoke-free policy in rural KentuckyTo test the effects of a community intervention on smoke-free policy outcomes in rural underserved communitiesNHLBIApril 1, 2007USR01CA124404Cancer control dissemination research among state-level policy makersTo increase the dissemination of evidence-based interventions to control cancer, primarily focusing on the uptake of effective environmental and policy approaches among state-level policy makersNCISeptember 27, 2007USR01MH072961Mixed methods study of EBP sustainment in a statewide service systemTo examine factors that either support or limit sustainment of an evidence-based child neglect intervention in a large statewide public service systemNIMHSeptember 22, 2005USR01CA160327Disseminating evidence-based interventions to control cancerTo increase the dissemination of EBPPs to control cancer, focusing on the uptake of effective approaches among state-level practitionersNCI/ODMay 3, 2012USR01DA030431To test a payer/treatment agency intervention to increase use of buprenorphineTo test whether clinician training and the use of organizational change strategies are sufficient for disseminating an evidence-based practice (EBP), or if changes to both organizational systems and payer policy result in greater EBP useNIDAMarch 1, 2012USR03CA128644Translating science into policy: a survey of state tobacco control plansTo examine the structures and processes used by states to develop strategic plans to reduce tobacco use and prevent initiationNCIJune 2, 2008USR21CA136435Workplace health promotionTo enhance the dissemination potential of a successful intervention, Workplace Solutions that was developed to disseminate a set of 15 evidence - based cancer prevention strategies to workplacesNCIJuly 16, 2009USR01MH104200Value-based purchasing in implementation of depression care in community clinicsTo assess the role of value-based purchasing (VBP), a policy strategy, to enhance planned implementation of evidence-based care in CHCsNIMHAugust 1, 2014USR01CA175329Implementing tobacco use treatment guidelines in community health centers in VietnamTo fill the current research-to-practice gap by conducting a randomized controlled trial that compares the effectiveness and cost effectiveness of two practical and highly replicable strategies for implementing evidence-based guidelines for the treatment of tobacco use in public health clinics in VietnamNCISeptember 30, 2013VietnamR21MH098124Development and validation of implementation climate measuresTo develop measures of organizational climate, leadership, and provider behaviors likely to impact the implementation of evidence-based practicesNIMHJune 24, 2013USR21CA172938A retail policy laboratory: modeling impact of retailer reduction on tobacco useTo examine the interplay between retailer density reductions and patterns of tobacco purchasingNCIJuly 1, 2013USR21AI095979Sustainable financial incentives to improve prescription practices for malariaTo test an innovative, sustainable financial incentive designed to reduce the number of non-malarial fevers that are treated inappropriately with antimalarial drugsNIAIDApril 1, 2012Kenya*US* United States, *NIH* National Institutes of Health, *NCI* National Cancer Institute, *NIMH* National Institute of Mental Health, *NIDA* National Institute on Drug Abuse, *NHLBI* National Heart, Lung, and Blood Institute, *OD* NIH Office of the Director, *NIAID* National Institute of Allergy and Infectious Diseases, *D&I* dissemination and implementation

Limitations {#Sec4}
-----------

We limited our review to projects funded through FOAs explicitly focused on D&I and may not have identified all NIH-funded policy D&I projects. Our review also did not capture policy D&I projects funded by other US government agencies or philanthropies. We did not attempt to obtain the full text of proposals and thus did not have complete information on project characteristics, such as information on how the projects planned to disseminate their findings. We also did not have data on the characteristics of policy D&I research proposals that were unsuccessful in obtaining funding through NIH. Thus, we were unable to identify specific characteristics that increased the likelihood of a policy D&I project being funded. We dichotomously categorized projects as policy D&I (yes/no) and did not differentiate between projects in which policy D&I was the primary focus or subcomponent. Because only 12 policy D&I projects were identified, subgroup differences and comparisons should be interpreted with caution.

Conclusions {#Sec5}
===========

NIH has made an initial investment in policy D&I research, signaling that the field might be entering the mainstream US health research enterprise. The level of support for policy D&I research, however, has varied between Institutes and is probably not commensurate with the potential of evidence-based policy to positively impact human health. Policy D&I researchers have utilized a variety of designs, methods, and data sources to investigate the development processes, content, and outcomes of public and private policies. By mapping the characteristics of NIH funded policy D&I research projects, the current study provides investigators with guidance on approaches to policy D&I research that they can consider when conceptualizing research ideas and developing NIH proposals in this area.

Additional file {#Sec6}
===============

Additional file 1:**NIH-funded policy D&I projects.** (XLSM 583 kb)
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